OPC: Explanation for business results for 6 months of 2013 before & after review
OPC Pharmaceutical Joint-Stock Company has explained for business results for the first six months of 2013 before & after review as follows:
By: VND
After auditing Before auditing Increase/ decrease Profit after tax 34,341,488,693 34,713,757,019 372,268,326 - Profit after tax decreased by VND372,268,326 mainly because of the following reasons: + Revenue increased by 36%, or VND34.83 billion. This helped OPC’s profit increase. - According to the request of auditors, OPC must distribute expenses as follows: + Selling expense: VND302,501,960 + Interest expense: VND193,855,807
After auditing
Before auditing
Increase/ decrease
Profit after tax
34,341,488,693
34,713,757,019
372,268,326
- Profit after tax decreased by VND372,268,326 mainly because of the following reasons:
+ Revenue increased by 36%, or VND34.83 billion. This helped OPC’s profit increase.
- According to the request of auditors, OPC must distribute expenses as follows:
+ Selling expense: VND302,501,960
+ Interest expense: VND193,855,807
HOSE
> STB: Explanation for business result in Quarter 2.2013 (20/08/2013)
> SGC: Reviewed financial statement 2013 (20/08/2013)
> SEL: Reviewed financial statement 2013 (20/08/2013)
> L35: Reviewed financial statement 2013 (20/08/2013)
> VC9: Financial Statement Quarter 2/2013 (consolidated) (20/08/2013)
> PSI: Reviewed financial statement 2013 (20/08/2013)
> BVS: Reviewed financial statement 2013 (20/08/2013)
> VC9: Financial Statement Quarter 2/2013 (holding company) (20/08/2013)
> BKC: Reviewed financial statement 2013 (holding company) (20/08/2013)
> NTP: Financial Statement Quarter 2/2013 (20/08/2013)